Favipiravir for the Treatment of Coronavirus Disease 2019; a propensity score-matched cohort study
Rand A. Alattar, Shiema Abdalla, Tasneem A.K. Abdallah, Rashid Kazman, Aseelah Qadmour, Tawheeda B. H. Ibrahim, Bassem Alhariri, Shahd H. Shaar, Abeer Bajwa, Abeir B. Alimam, Rabia Qazi, Fatma Ben Abid, Joanne Daghfal, Ali M. Eldeeb, Kinda Shukri, Ahmed Elsayed, Fatima Rustom, Musaed Alsamawi, Alaaeldin Abdelmajid, Miguel A. P. Basulto, Armando A. R. Cobian, Mohamed Abukhattab, Muna A. Almaslamani, Abdullatif Alkhal, View ORCID ProfileAli S. Omrani
doi: https://doi.org/10.1101/2021.11.29.21267042
Rand A. Alattar
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Shiema Abdalla
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Tasneem A.K. Abdallah
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Rashid Kazman
bDivision of Internal Medicine, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
Aseelah Qadmour
bDivision of Internal Medicine, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
Tawheeda B. H. Ibrahim
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Bassem Alhariri
bDivision of Internal Medicine, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
Shahd H. Shaar
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Abeer Bajwa
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Abeir B. Alimam
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Rabia Qazi
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Fatma Ben Abid
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Joanne Daghfal
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Ali M. Eldeeb
cDepartment of Clinical Imaging, Hamad Medical Corporation, Doha, Qatar
Kinda Shukri
cDepartment of Clinical Imaging, Hamad Medical Corporation, Doha, Qatar
Ahmed Elsayed
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Fatima Rustom
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Musaed Alsamawi
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Alaaeldin Abdelmajid
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
Miguel A. P. Basulto
bDivision of Internal Medicine, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
Armando A. R. Cobian
bDivision of Internal Medicine, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
Mohamed Abukhattab
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
dDivision of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
Muna A. Almaslamani
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
dDivision of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
Abdullatif Alkhal
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
dDivision of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
Ali S. Omrani
aCommunicable Disease Center, Hamad Medical Corporation, Doha, Qatar
dDivision of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
Posted November 30, 2021.
Favipiravir for the Treatment of Coronavirus Disease 2019; a propensity score-matched cohort study
Rand A. Alattar, Shiema Abdalla, Tasneem A.K. Abdallah, Rashid Kazman, Aseelah Qadmour, Tawheeda B. H. Ibrahim, Bassem Alhariri, Shahd H. Shaar, Abeer Bajwa, Abeir B. Alimam, Rabia Qazi, Fatma Ben Abid, Joanne Daghfal, Ali M. Eldeeb, Kinda Shukri, Ahmed Elsayed, Fatima Rustom, Musaed Alsamawi, Alaaeldin Abdelmajid, Miguel A. P. Basulto, Armando A. R. Cobian, Mohamed Abukhattab, Muna A. Almaslamani, Abdullatif Alkhal, Ali S. Omrani
medRxiv 2021.11.29.21267042; doi: https://doi.org/10.1101/2021.11.29.21267042
Favipiravir for the Treatment of Coronavirus Disease 2019; a propensity score-matched cohort study
Rand A. Alattar, Shiema Abdalla, Tasneem A.K. Abdallah, Rashid Kazman, Aseelah Qadmour, Tawheeda B. H. Ibrahim, Bassem Alhariri, Shahd H. Shaar, Abeer Bajwa, Abeir B. Alimam, Rabia Qazi, Fatma Ben Abid, Joanne Daghfal, Ali M. Eldeeb, Kinda Shukri, Ahmed Elsayed, Fatima Rustom, Musaed Alsamawi, Alaaeldin Abdelmajid, Miguel A. P. Basulto, Armando A. R. Cobian, Mohamed Abukhattab, Muna A. Almaslamani, Abdullatif Alkhal, Ali S. Omrani
medRxiv 2021.11.29.21267042; doi: https://doi.org/10.1101/2021.11.29.21267042
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2767)
- Dermatology (236)
- Emergency Medicine (415)
- Epidemiology (12420)
- Forensic Medicine (10)
- Gastroenterology (785)
- Genetic and Genomic Medicine (4284)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2765)
- Health Policy (1024)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4061)
- Nursing (218)
- Nutrition (602)
- Oncology (2143)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6665)
- Radiology and Imaging (1455)
- Respiratory Medicine (887)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (194)
- Urology (171)